DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 022578
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 022578
Tradename: | ZYRTEC ALLERGY |
Applicant: | J And J Consumer Inc |
Ingredient: | cetirizine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 022578
Suppliers and Packaging for NDA: 022578
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022578 | NDA | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 50580-778 | 50580-778-24 | 4 BLISTER PACK in 1 CARTON (50580-778-24) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022578 | NDA | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 50580-782 | 50580-782-01 | 2 CARTON in 1 PACKAGE (50580-782-01) > 4 BLISTER PACK in 1 CARTON > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
Approval Date: | Sep 3, 2010 | TE: | RLD: | Yes |
Complete Access Available with Subscription